Building smart cell therapies that sense problems and act safely
Design-driven engineering of robust mammalian sense-and-respond functions: from parts to programs
This project develops engineered cells that can detect disease signals and respond safely to help people with cancer, autoimmune disease, or tissue damage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11310803 on NIH RePORTER |
What this research studies
Researchers are creating tools to design and build living cells that can sense their environment, remember past signals, and act only when appropriate. They will combine lab experiments and computer design tools to speed up how genetic 'programs' are put together and tested. The work focuses on using natural mechanisms of genetic memory and building reliable sense-and-respond circuits in mammalian cells. The goal is to accelerate safer, more precise cell therapies for cancer, autoimmune disorders, and regenerative medicine.
Who could benefit from this research
Good fit: People with cancers, autoimmune conditions, or injuries needing tissue regeneration are the kinds of patients who could eventually be candidates for related clinical trials.
Not a fit: Patients with conditions unrelated to immune, cancer, or tissue-repair approaches likely will not see direct benefits from this work in the near term.
Why it matters
Potential benefit: If successful, this could lead to safer, more targeted cell therapies that work for a wider range of cancers, autoimmune illnesses, and tissue repair needs.
How similar studies have performed: Related approaches such as CAR-T cell therapies have produced dramatic benefits in some cancers, while the specific engineering tools here are newer and remain largely preclinical.
Where this research is happening
Chicago, UNITED STATES
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Leonard, Joshua Nathaniel — Northwestern University
- Study coordinator: Leonard, Joshua Nathaniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.